Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Vaxess Technologies logo — Forging a path to more convenient, self-empowered, and acces...

Vaxess Technologies

Forging a path to more convenient, self-empowered, and accessible healthcare

Founded 2012 United States Boston, United States 61 employees Venture round Total: $83.24M Biotechnology, Health Care

General Information

Company Name Vaxess Technologies
Founded Year 2012
Location United States Boston, United States
Employees 61
Industries Biotechnology, Health Care
Funding Stage Venture round
Business Model B2B, B2D, Platform
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Vaxess Technologies. To contact Vaxess Technologies, visit vaxess.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vaxess Technologies compare?

A PDF of Vaxess Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vaxess Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vaxess Technologies

Vaxess Technologies, established in 2012, is positioning itself as a transformative force in the Biotechnology and Health Care industries. The company is dedicated to making healthcare more convenient, self-empowered, and accessible through its innovative delivery platform.

The platform features a proprietary microarray patch and applicator, which allows for precise dose delivery of advanced therapies without the need for refrigeration. This approach not only enhances convenience but also extends the reach of critical healthcare delivery to low-resource settings.

To date, Vaxess Technologies has secured over $100 million in funding from prominent investors such as RA Capital Management, Engine Ventures, GHIC, Mission BioCapital, and notable funding bodies like BARDA, DARPA, NIH, NSF, and the Gates Foundation. Their latest financing achievement includes a $12.00 million Venture Round investment on May 22, 2024.

Business keywords: Microarray Patch Technology, Sustained Release Vaccines, Next-Generation Therapies, Dose Delivery Control, Non-Refrigerated Delivery, Low-Resource Settings Delivery, Therapeutic Patch Platforms, Biomaterials Innovation, Immune Response Enhancement, Venture Capital Funding, Clinical Proof of Concept, In-vivo Efficacy, Stability Engineered Solutions, Grant Funding from Health Agencies, Payload Customization

Services & Products

Development of microarray patch platforms
Delivery of next-gen therapies using MAP
Temperature stable drug delivery solutions

Target Customers

Patients seeking convenient healthcare solutions Individuals needing temperature stable treatments Healthcare providers looking for innovative delivery methods

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $12.00M 4
RA Capital Management Global Health Investment Corporation Mission BioCapital
RA Capital Management, Global Health Investment Corporation +2
22 May 2024
Venture Round $9.00M 4
Ulu Ventures RA Capital Management The Engine
Ulu Ventures, RA Capital Management +2
13 Sep 2023
Series B $10.00M 3
RA Capital Management The Engine Mission BioCapital
RA Capital Management, The Engine +1
10 Jan 2023
Series B $27.00M 4
RA Capital Management The Engine Global Health Investment Corporation
RA Capital Management, The Engine +2
02 Nov 2022
Series A $8.20M 3
The Engine Mission BioCapital BioInnovation
The Engine, Mission BioCapital +1
27 Jun 2019
Venture Round $3.58M -
15 Feb 2019
Grant $6.00M 1
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
28 Feb 2017
Venture Round $862.86K 1
BioInnovation
BioInnovation
30 Jan 2017
Grant $1.41M 1
National Science Foundation
National Science Foundation
20 Sep 2016
Grant $220.00K 1
National Institutes of Health
06 Apr 2015

View All 15 Funding Rounds

Vaxess Technologies Alternatives & Competitors

Vaxess Technologies vs
Ro5
Ro5 United Kingdom

Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.

Seed
12 employees
AI, Biotechnology
Compare Vaxess Technologies vs Ro5

FAQ About Vaxess Technologies

Forging a path to more convenient, self-empowered, and accessible healthcare
Vaxess Technologies was founded in 2012.
Vaxess Technologies is headquartered in Boston, United States.
Vaxess Technologies operates in Biotechnology and Health Care. Its work centres on Microarray Patch Technology, Sustained Release Vaccines, Next-Generation Therapies and Dose Delivery Control. Its customers include Patients seeking convenient healthcare solutions, Individuals needing temperature stable treatments and Healthcare providers looking for innovative delivery methods.
Vaxess Technologies has a B2B, B2D and Platform business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Vaxess Technologies has approximately 61 employees.
Vaxess Technologies has completed 15 funding rounds, raising a total of $83.24M. The latest funding stage is Venture round.
Vaxess Technologies offers: Development of microarray patch platforms, Delivery of next-gen therapies using MAP, Temperature stable drug delivery solutions.
Top alternatives and competitors to Vaxess Technologies include Ro5. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaxess Technologies and Ro5 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vaxess Technologies, https://bouncewatch.com/company/vaxess-technologies, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes